Doença Glomerular Online (Glomerular Disease)

Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving global outcomes (KDIGO) Controversies Conference

J Floege, S J Barbour, D C Cattrans et al

Kidney International 2019, vol 95 (2): 268-280

https://www.kidney-international.org/article/S0085-2538(18)30809-3/fulltext

 

Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving global outcomes (KDIGO) Controversies Conference

B H Rovin, D J Caster, D C Cattran et al

Kidney International 2019, vol 95 (2): 291-295

https://www.kidney-international.org/article/S0085-2538(18)30811-1/fulltext

 

Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium

A R Chang, M E Grams, S H Ballew et al

BMJ 2019, vol 364: k5301

https://www.bmj.com/content/364/bmj.k5301

 

Abdominal obesity and reduction of glomerular filtration.

Dias, Raimunda Sheyla Carneiro et al.

Rev. Assoc. Med. Bras., Apr 2018, vol.64, no.4, p.346-353

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302018000400346&lng=en&nrm=iso&tlng=en

 

Rituximab for anti-glomerular basement membrane disease

Rashmi Jain, Hanna Dgheim, Andrew S. Bomback

Kidney Int Rep. 2019 Apr; 4(4): 614–618

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451084/

 

Dysproteinemias and glomerular disease

Nelson Leung, Maria E. Drosou, Samih H. Nasr

Clin J Am Soc Nephrol. 2018 Jan 6; 13(1): 128–139

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753301/

 

Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+) : conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO)

K Eckardt, N Bansal, J Coresh et al

Kidney International 2018, vol 93 (6): p1281-1292

https://www.kidney-international.org/article/S0085-2538(18)30136-4/fulltext

 

Toward individual glomerular phenotyping: advent of precision medicine in kidney biopsies

K Sharma, L Pasa-Tolic

Kidney International 2018, vol 93 (6): p1265-81-1267

https://www.kidney-international.org/article/S0085-2538(18)30192-3/fulltext

 

The glomerular disease study and trial consortium: a grassroots initiative to foster collaboration and innovation

Ali Poyan Mehr, Maryam Sadeghi-Najafabadi, Kristi Chau et al

Kidney Int Rep. 2019 Jan; 4(1): 20–29

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308822/

 

Glomerular disease in women

Kate Wiles, Liz Lightstone

Kidney Int Rep. 2018 Mar; 3(2): 258–270

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932310/

 

Glucocorticoids in the treatment of glomerular diseases: pitfalls and pearls

Claudio Ponticelli, Francesco Locatelli

Clin J Am Soc Nephrol. 2018 May 7; 13(5): 815–82

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969489/

 

■  Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Novo endereço:

Consultório: Rua Padre Rolim 815/sala 815

Tel: 33245518 (Consulta Particular/Unimed)

 

– Centro Médico Unimed BH/Contagem/Pedro I

Belo Horizonte/MG/Brasil

CRMMG: 7026

Email: pfleite1873@gmail.com

Doença Renal Policística Online (Polycystic Kidney Disease)

¨A doença renal policística hereditária é uma desordem genética, podendo ser de caráter autossômica dominante (DRPAD) ou autossômica recessiva (DRPRD). Corresponde a uma insuficiência renal crônica de progressão lenta, caracterizada pelo desenvolvimento e crescimento progressivos de cistos renais, que começam a ser detectáveis quando já são tão numerosos e grandes, que ocupam o lugar do tecido renal normal, comprimindo-o e destruindo-o com o tempo, levando à falência renal terminal. A doença renal policística autossômica dominante (DRPAD) é a enfermidade renal hereditária mais comum em seres humanos. Reconhecida como doença monogênica multissistêmica, é caracterizada por progressivo crescimento e desenvolvimento de múltiplos cistos renais bilaterais que destroem o parênquima funcional, bem como por manifestações extrarrenais (cistos em outros órgãos, anormalidade valvular cardíaca, aneurismas cerebrais, hérnias abdominais, dores pelo corpo, colecistopatia calculosa e doença diverticular).¨

 

Urinary T cells correlate with rate of renal function in autosomal dominant polycystic kidney disease

Kurt A. Zimmerman, Nancy M. Gonzalez, Phillip Chumley, et al

Physiol Rep. 2019 Jan; 7(1): e13951

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328912/

 

Management of autosomal-dominant polycystic kidney disease – state-of-the-art

Roman-Ulrich Müller, Thomas Benzing

Clin Kidney J. 2018 Dec; 11(Suppl 1): i2–i13

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295602/

 

Updated Canadan Expert Consensus on assessing risk of disease progression and pharmacological management of autosomal dominant polycystic kidney disease

Steven Soroka, Ahsan Alam, Micheli Bevilacqua et al

Can J Kidney Health Dis. 2018; 5: 2054358118801589

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187423/

 

Urinary biomarkers to identify autosomal dominant polycystic kidney disease patients with a high likelihood of disease progression

  1. Lianne Messchendorp, Esther Meijer, Wendy E. Boertien

DIPAK Consortium

Kidney Int Rep. 2018 Mar; 3(2): 291–301

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932128/

 

A case of congenital left ventricular diverticulum in a patient with autosomal dominant polycystic kidney disease: possible mechanistic link beteween polycystin and ventricular diverticulum

Seishi Aihara, Shunsuke Yamada, Hidenori Matsusaka, Rami Tashiro et al

CEN Case Rep. 2018 Nov; 7(2): 237–242

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181890/

 

Genetics of autosomal recessive polycystic kidney disease and its differential diagnoses

Carsten Bergmann

Front Pediatr. 2017; 5: 221

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811498/

 

Practical approaches to the management of autosomal dominant polycystic kidney disease patients in the era of tolvaptan

Roman-Ulrich Müller, Christian S Haas, John A Sayer

Clin Kidney J. 2018 Feb; 11(1): 62–69

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798152/

 

Infected renal cyst presented with pleural effusion in a woman with autosomal dominant polycystic kidney disease

Ester Casillas-Sagrado, Victor Burguera, Maria Eugenia Rioja-Martín, Maite Rivera-Gorrín

Clin Kidney J. 2018 Apr; 11(2): 204–206

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888413/

 

Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice

R T Gansevoort M A Thomas, B Henrik et al

Nephrology Dialysis Transplantation 2016, vol 31 (3): 337-348

https://academic.oup.com/ndt/article/31/3/337/2460159

 

Resultado do transplante renal com doador portador de doença renal policística

Migone, Silvia Regina da Cruz et al.

  1. Bras. Nefrol., Sept 2016, vol.38, no.3, p.379-382

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002016000300379&lng=en&nrm=iso&tlng=pt

 

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002016000300379&lng=en&nrm=iso&tlng=en (english)

 

Unexpected relevance of the hallmarks of cancer to the pathogenesis of polycystic kidney disease

Tamina Seeger-Nukpezah, Daniel M. Geynisman, Anna S. Nikonova et al

Rev Nephrol. 2015 Sep; 11(9): 515–534

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902186/

 

Doença renal policística autossômica dominante em pacientes em hemodiálise no sul do Brasil

Alves, Everton Fernando et al.

J Bras Nefrol, Mar 2014, vol.36, no.1, p.18-2

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002014000100018&lng=en&nrm=iso

 

Autosomal dominant polycystic kidney disease

A Srivastava, N Patel

Am Fam Physician 2014, vol 90 (5): 303-307

https://www.aafp.org/afp/2014/0901/p303.html

 

Hereditary polycystic kidney disease: genetic diagnosis and counseling.

Whittle, Martin and Simões, Ricardo

Rev. Assoc. Med. Bras., 2014, vol.60, no.2, p.98-102. ISSN 0104-4230

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302014000200098&lng=en&nrm=iso

 

Pain determinants of pain in autosomal dominant polycystic kidney disease

Nishiura, José Luiz, Eloi, Samara Rodrigues Moreira and Heilberg, Ita Pfeferman

  1. Bras. Nefrol., Sept 2013, vol.35, no.3, p.242-243

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002013000300012&lng=en&nrm=iso&tlng=en

 

Ansiedade, depressão e qualidade de vida em pacientes com glomerulonefrite familiar ou doença renal policística autossômica dominante

Barros, Bruna Paes de et al.

  1. Bras. Nefrol., Jun 2011, vol.33, no.2, p.120-128

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002011000200002&lng=en&nrm=iso

 

Tradução, adaptação cultural e aplicação de um questionário de dor para pacientes com doença renal policística.

Eloi, Samara Rodrigues Moreira, Nishiura, José Luiz and Heilberg, Ita Pfeferman

  1. Bras. Nefrol., Dez 2010, vol.32, no.4, p.393-407

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002010000400009&lng=en&nrm=iso

 

Dias, Natasha Favoretto et al. Aspectos clínicos da doença renal policística autossômica recessiva DRPARJ. Bras. Nefrol., Set 2010, vol.32, no.3, p.263-267

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002010000300007&lng=en&nrm=iso

 

Aneurismas das artérias coronárias: uma rara manifestação da doença renal policística autossômica dominante

Velásquez, Alejandro Sánchez et al.

Rev. Bras. Cardiol. Invasiva, 2010, vol.18, no.4, p.476-478

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2179-83972010000400020&lng=en&nrm=iso

 

■  Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Novo endereço:

Consultório: Rua Padre Rolim 815/sala 815

Tel: 33245518 (Consulta Particular/Unimed)

 

– Centro Médico Unimed BH/Contagem/Pedro I

Belo Horizonte/MG/Brasil

CRMMG: 7026

Email: pfleite1873@gmail.com